Morning folks,
Sitting in clinic at Sarah Cannon Research Institute in Nashville getting my first dose of Phase 1 trial of a Xencor drug called XmAb808, which is an antibody that binds to tumor cells and immune cells called T cells.
Baseline scans looked decent and all systems are go.
Really blessed to have this available to me even if it is three hour drive each way.
These people are really good and caring.
Updates to follow.